First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (LON:FBT – Get Free Report)’s share price fell 0.2% during mid-day trading on Thursday . The company traded as low as GBX 1,549.84 ($20.27) and last traded at GBX 1,559.60 ($20.39). 97 shares were traded during mid-day trading, a decline of 94% from the average session volume of 1,751 shares. The stock had previously closed at GBX 1,563.40 ($20.44).
First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Stock Performance
The firm’s 50 day moving average is GBX 1,551.60 and its 200 day moving average is GBX 1,491.27. The company has a debt-to-equity ratio of 0.04, a quick ratio of 9.27 and a current ratio of 9.42. The stock has a market cap of £4.61 billion and a P/E ratio of -1,417.82.
About First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation
Forbidden Technologies plc develops and owns cloud-based video technology in the United Kingdom, North America, and internationally. It offers Forscene, a cloud based video post-production and publishing platform with various applications, such as editing, adding closed caption, graphics, metadata fast, remote viewing, collaboration, and publishing content.
Read More
- Five stocks we like better than First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation
- 3 Monster Growth Stocks to Buy Now
- 3 Leveraged ETFs to Multiply Returns
- Using the MarketBeat Stock Split Calculator
- A Tale of Two Titans: Unveiling the Value in Baidu and JD.com
- What is a Secondary Public Offering? What Investors Need to Know
- Is the AI-Capable iPhone 16 the Start of a Sales Super-Cycle?
Receive News & Ratings for First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation and related companies with MarketBeat.com's FREE daily email newsletter.
